Clinical Trials Browser

Gaucher Disease × Cyclophosphamide × 90 days × Clear all

NCT03721068 2026-03-27

Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma

Phase 1 Recruiting

Gaucher Disease, Neuroblastoma, Osteosarcoma